Kim Kramer
- Neurology top 0.2%
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 2%
- Genetics top 1%
- Co-authors
- Nai‐Kong V. CheungBrian H. KushnerShakeel ModakMichael P. LaQuagliaSteven M. LarsonIrene Y. CheungGlenn HellerSuzanne L. Wolden
- Topics
- Neuroblastoma Research and Treatments (123 papers)Glioma Diagnosis and Treatment (50 papers)Cancer therapeutics and mechanisms (39 papers)
- Cited by
- NeurologyGeneticsCancer Research
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Kim Kramer
156 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 113
- Neurology 3.2k
- Molecular Biology 1.8k
- Oncology 1.4k
- Cancer Research 985
- Genetics 912
Countries citing papers authored by Kim Kramer
This map shows the geographic impact of Kim Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Kramer more than expected).
Fields of papers citing papers by Kim Kramer
This network shows the impact of papers produced by Kim Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Kramer. The network helps show where Kim Kramer may publish in the future.
Co-authorship network of co-authors of Kim Kramer
This figure shows the co-authorship network connecting the top 25 collaborators of Kim Kramer. A scholar is included among the top collaborators of Kim Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Kramer. Kim Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 31 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 20 | |
| 8 | 70 | |
| 9 | 10 | |
| 10 | 25 | |
| 11 | 17 | |
| 12 | 9 | |
| 13 | 10 | |
| 14 | 27 | |
| 15 | 109 | |
| 16 | 81 | |
| 17 | 15 | |
| 18 | 16 | |
| 19 | 52 | |
| 20 | Bone sialoprotein is expressed in both human neuroblastoma tissues and cell lines | 2 |
About Kim Kramer
Kim Kramer is a scholar working on Neurology, Genetics and Cancer Research, having authored 164 papers that have together received 5.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (123 papers), Glioma Diagnosis and Treatment (50 papers) and Cancer therapeutics and mechanisms (39 papers). The work is most often cited by research in Neurology (3.2k citations), Genetics (912 citations) and Cancer Research (985 citations). Kim Kramer has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Nai‐Kong V. Cheung, Brian H. Kushner, Shakeel Modak, Michael P. LaQuaglia, Steven M. Larson, Irene Y. Cheung, Glenn Heller, Suzanne L. Wolden, William L. Gerald and Mark M. Souweidane. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.